Trial intelligence / Profile preview

BAM8-22 as a Surrogate Model of Non-histaminergic Itch

NCT04197440Unknown

Sponsor
Aalborg University
Start
Jan 2020
Primary completion
May 2020
Modality
Peptides, Small Molecules
Countries
1
01

Overview

Trial of BAM8-22 in pruritus, sponsored by Aalborg University. Primary endpoints: Superficial blood perfusion at 10 minutes and Warm Detection Threshold at 10 minutes. Status: unknown.

02

Drugs

BAM8-22
03

Conditions

pruritus

Beyond the preview

Go deeper on NCT04197440.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04197440.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call